Literature DB >> 10755689

Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands, Japan.

Y Kato1, K Nakao, K Hamasaki, H Kato, K Nakata, Y Kusumoto, K Eguchi.   

Abstract

Annual mass examination was performed between 1972 and 1997 in Tomie-town, Goto Islands, Japan, where hepatitis B virus (HBV) infection is very prevalent. In the present study, the incidence of spontaneous loss of hepatitis B surface antigen (HBsAg) in HBsAg carriers was determined in this area. Three thousand and nineteen inhabitants were tested for HBsAg two or more times in our annual surveys. Among them, 131 (4.3%) were defined as chronic HBsAg carriers based on the persistence of HBsAg for 1 or more years. These 131 subjects were followed for 12.2 +/- 7.6 years. During the follow-up period, spontaneous loss of HBsAg occurred in 38 (29%) of the 131 carriers, with a yearly incidence of 2.5%. This loss was seen more frequently in carriers aged 40 years or more on enrollment than in those aged less than 40 years during the same observation periods (P = 0.0141), irrespective of sex or the results of liver function tests. The values for liver function test results were similar before and after loss of HBsAg in these carriers. Stored serum samples were available for later analysis of HBV-DNA by polymerase chain reaction in 32 carriers with loss of HBsAg. The HBV-DNA sequence was detected in 26 (81%) and 2 of the 32 carriers (6%) before and after loss of HBsAg, respectively. These results indicate that spontaneous loss of HBsAg, largely attributable to clearance of viremia, occurs age-dependently in chronic carriers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10755689     DOI: 10.1007/s005350050331

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  13 in total

Review 1.  Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies.

Authors:  Ralph Carmel; Mona Sarrai
Journal:  Curr Hematol Rep       Date:  2006-03

2.  Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.

Authors:  Kali Zhou; Caitlin Contag; Evans Whitaker; Norah Terrault
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-01-22

3.  Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.

Authors:  Wendy K Foster; Darren S Miller; Catherine A Scougall; Ieva Kotlarski; Richard J Colonno; Allison R Jilbert
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection.

Authors:  L H Nguyen; J Hoang; N H Nguyen; V D Vu; C Wang; H N Trinh; J Li; J Q Zhang; M H Nguyen
Journal:  Aliment Pharmacol Ther       Date:  2016-07-01       Impact factor: 8.171

5.  Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized, controlled trials.

Authors:  Michael McCulloch; Michael Broffman; Jin Gao; John M Colford
Journal:  Am J Public Health       Date:  2002-10       Impact factor: 9.308

6.  Prevalence and presentation of hepatitis B and C virus (HBV and HCV) infection in Vietnamese Americans via serial community serologic testing.

Authors:  Kelvin Nguyen; Thai Van Nguyen; Duke Shen; Victor Xia; Diep Tran; Khanh Banh; Victor Ruan; Ke-Qin Hu
Journal:  J Immigr Minor Health       Date:  2015-02

7.  Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up.

Authors:  Mariko Kobayashi; Tetsuya Hosaka; Fumitaka Suzuki; Norio Akuta; Hitomi Sezaki; Yoshiyuki Suzuki; Yusuke Kawamura; Masahiro Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Yuzo Miyakawa; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2013-06-20       Impact factor: 7.527

8.  Clinical outcomes of delayed clearance of serum HBsAG in patients with chronic HBV infection.

Authors:  Soon Woo Nam; Jeong Jo Jung; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon; Se Hyun Cho; Joon Yeol Han; Nam Ik Han; Jin Mo Yang; Young Suk Lee
Journal:  Korean J Intern Med       Date:  2007-06       Impact factor: 2.884

9.  Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.

Authors:  Young Min Park; Seong Gyu Lee
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

10.  Hepatitis B Virus Inactive Carriers: Which Follow-up Strategy?

Authors:  Maria João Magalhães; Isabel Pedroto
Journal:  GE Port J Gastroenterol       Date:  2015-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.